Improving Subject Safety in High-Risk Phase I Trials With Stem Cell-Based Candidate Therapies
American Journal of Bioethics Neuroscience 3 (2):18-20 (2012)
Abstract
This article has no associated abstract. (fix it)DOI
10.1080/21507740.2012.675008
My notes
Similar books and articles
Safety Issues In Cell-Based Intervention Trials.Liza Dawson, Alison S. Bateman-House, Dawn Mueller Agnew, Hilary Bok, Dan W. Brock, Aravinda Chakravarti, Mark Greene, Patricia King, Stephen J. O'Brien, David H. Sachs, Kathryn E. Schill, Andrew Siegel & Davor Solter - 2003 - Fertility and Sterility 80 (5):1077-1085.
Allowing Innovative Stem Cell-Based Therapies Outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
International stem cell tourism and the need for effective regulation: Part II: Developing sound oversight measures and effective patient support.Cynthia B. Cohen Peter J. Cohen - 2010 - Kennedy Institute of Ethics Journal 20 (3):207-230.
Evaluating the First-in-Human Clinical Trial of a Human Embryonic Stem Cell-Based Therapy.Audrey R. Chapman & Courtney C. Scala - 2012 - Kennedy Institute of Ethics Journal 22 (3):243-261.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is it Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - American Journal of Bioethics Neuroscience 3 (2):20-22.
Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury.Frederic Bretzner, Frederic Gilbert, Françoise Baylis & Robert M. Brownstone - 2011 - Cell Stem Cell 8 (5):468-475.
Which patient groups should be asked to participate in first-in-human trials of stem-cell-based therapies?Kristina Hug & Göran Hermerén - 2012 - Journal of Clinical Ethics 23 (3):256-271.
Design and implementation of the START trial, a phase 1/2 trial of human mesenchymal stem/stromal cells for the treatment of moderate-severe acute respiratory distress syndrome. [REVIEW]K. D. Liu, J. G. Wilson, H. Zhuo, L. Caballero, M. L. McMillan, X. Fang, K. Cosgrove, C. S. Calfee, J. W. Lee, K. N. Kangelaris, J. E. Gotts, A. J. Rogers, J. E. Levitt, J. P. Wiener-Kronish, K. L. Delucchi, A. D. Leavitt, D. H. McKenna, B. T. Thompson & M. A. Matthay - unknown
Allowing Innovative Stem Cell-Based Therapies outside of Clinical Trials: Ethical and Policy Challenges.Insoo Hyun - 2010 - Journal of Law, Medicine and Ethics 38 (2):277-285.
The Roles and Responsibilities of Physicians in Patients' Decisions about Unproven Stem Cell Therapies.Aaron D. Levine & Leslie E. Wolf - 2012 - Journal of Law, Medicine and Ethics 40 (1):122-134.
Uncertain translation, uncertain benefit and uncertain risk: Ethical challenges facing first-in-human trials of induced pluripotent stem (ips) cells.Ronald K. F. Fung & Ian H. Kerridge - 2013 - Bioethics 27 (2):89-96.
Ethical and policy issues relating to progenitor-cell-based strategies for prevention of atherosclerosis.S. Matthew Liao, P. J. Goldschmidt & J. Sugarman - 2007 - Journal of Medical Ethics 33 (11):643-646.
Translating Stem Cell Research: Challenges at the Research Frontier.David Magnus - 2010 - Journal of Law, Medicine and Ethics 38 (2):267-276.
Differentiation of pluripotent stem cells into retinal pigmented epithelium.R. H. Croze & D. O. Clegg - unknown
Starting clinical trials of xenotransplantation--reflections on the ethics of the early phase.S. Welin - 2000 - Journal of Medical Ethics 26 (4):231-236.
Analytics
Added to PP
2018-06-22
Downloads
10 (#890,924)
6 months
1 (#454,876)
2018-06-22
Downloads
10 (#890,924)
6 months
1 (#454,876)
Historical graph of downloads
References found in this work
Addressing the Ethical Challenges of First in-Human Trials.Audrey R. Chapman - 2011 - Journal of Clinical Research and Bioethics 2 (4).
RAC Oversight of Gene Transfer Research: A Model Worth Extending?Nancy M. P. King - 2002 - Journal of Law, Medicine and Ethics 30 (3):381-389.
Intracranial Stem Cell-Based Transplantation: Reconsidering the Ethics of Phase 1 Clinical Trials in Light of Irreversible Interventions in the Brain.Pascale Hess - 2012 - American Journal of Bioethics Neuroscience 3 (2):3-13.
